Sheraton Steamboat Resort Floorplan
Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
This meeting took place in 2002
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Mechanisms and Applications of Immune Tolerance (D1)
Organizer(s) Jeffrey A. Bluestone, Abul K. Abbas and Christopher C. Goodnow
April 3—9, 2002
Sheraton Steamboat Resort • Steamboat Springs, Colorado USA
Abstract Deadline: Dec 3, 2001
Late Abstract Deadline:
Scholarship Deadline:
Early Registration Deadline: Feb 4, 2002
Sponsored by The Director's Sponsor Fund
Summary of Meeting:
The idea of reprogramming immune cells in a way that would eliminate pathogenic responses while preserving normal immune function is a concept that has tantalized immunologists for decades. Current immunotherapeutic drugs have met with a degree of clinical success, however, such therapies require lifelong usage and non-specifically suppress the entire immune system. Recent conceptual advances in our understanding of the mechanisms operative in the induction of tolerance and restoration of self-tolerance provide unprecedented insights into the development of new tolerogenic strategies. However, major challenges remain. What are the biochemical and molecular events that lead to tolerance? How do the central and peripheral mechanisms of tolerance interact? This meeting will bring together researchers to present recent breakthroughs in the study of the processes that regulate tolerance: clonal deletion; clonal inactivation; immune deviation and suppression. The topics will include: T and B cell receptor signaling; co-stimulation; accessory cell function; cell survival; and the intracellular signaling events that control immune tolerance. Finally, specific talks in immunotherapy of autoimmunity, transplantation, cancer and infectious disease will be included.
View Scholarships/Awards
The idea of reprogramming immune cells in a way that would eliminate pathogenic responses while preserving normal immune function is a concept that has tantalized immunologists for decades. Current immunotherapeutic drugs have met with a degree of clinical success, however, such therapies require lifelong usage and non-specifically suppress the entire immune system. Recent conceptual advances in our understanding of the mechanisms operative in the induction of tolerance and restoration of self-tolerance provide unprecedented insights into the development of new tolerogenic strategies. However, major challenges remain. What are the biochemical and molecular events that lead to tolerance? How do the central and peripheral mechanisms of tolerance interact? This meeting will bring together researchers to present recent breakthroughs in the study of the processes that regulate tolerance: clonal deletion; clonal inactivation; immune deviation and suppression. The topics will include: T and B cell receptor signaling; co-stimulation; accessory cell function; cell survival; and the intracellular signaling events that control immune tolerance. Finally, specific talks in immunotherapy of autoimmunity, transplantation, cancer and infectious disease will be included.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
WEDNESDAY, APRIL 3
THURSDAY, APRIL 4
FRIDAY, APRIL 5
SATURDAY, APRIL 6
SUNDAY, APRIL 7
MONDAY, APRIL 8
TUESDAY, APRIL 9
Conference Program Print | View meeting in 12 hr (am/pm) time
WEDNESDAY, APRIL 3
19:30—20:30
Keynote Address
Meeting has ended...abstracts no longer viewable online.
Hugh O. McDevitt,
Stanford University, USA
Tolerance and Autoimmunity
Tolerance and Autoimmunity
08:00—11:00
Central T Cell Tolerance
Meeting has ended...abstracts no longer viewable online.
Jonathan Sprent,
Garvan Institute, Australia
Requirements for Negative Selection of Thymocytes
Requirements for Negative Selection of Thymocytes
Bruno A. Kyewski,
German Cancer Research Center, Germany
'Promiscuous' Gene Expression and Immunological Self Tolerance: An Intricate Interface
'Promiscuous' Gene Expression and Immunological Self Tolerance: An Intricate Interface
*
Ronald N. Germain,
NIAID, National Institutes of Health, USA
Molecular Mechanisms Underlying Ligand-Selective Signaling in Immature and Mature T Cells
Molecular Mechanisms Underlying Ligand-Selective Signaling in Immature and Mature T Cells
17:00—19:00
B Cell Tolerance - 1
Meeting has ended...abstracts no longer viewable online.
Mark J. Shlomchik,
University of Pittsburgh School of Medicine, USA
Loss of B Cell Tolerance in Systemic Autoimmunity
Loss of B Cell Tolerance in Systemic Autoimmunity
*
Anthony L. DeFranco,
University of California, San Francisco, USA
Autoimmunity and B Cell Tolerance Defects in Lyn-Deficient Mice
Autoimmunity and B Cell Tolerance Defects in Lyn-Deficient Mice
Richard A. Flavell,
HHMI/Yale University School of Medicine, USA
Genetic Manipulation of Tolerance
Genetic Manipulation of Tolerance
20:00—22:00
Poster Session 1: Central T Cell Tolerance/B Cell Tolerance - 1
08:00—11:00
B Cell Tolerance - 2
Meeting has ended...abstracts no longer viewable online.
Jan S. Erikson,
Wistar Institute, USA
Regulation of Autoreactive B Cells in Healthy and Autoimmune Mice
Regulation of Autoreactive B Cells in Healthy and Autoimmune Mice
Timothy W. Behrens,
Genentech, Inc., USA
Regulation of Receptor Editing and Allelic Exclusion in Immature B Cells
Regulation of Receptor Editing and Allelic Exclusion in Immature B Cells
*
Christopher C. Goodnow,
Garvan Institute of Medical Research, Australia
Failure to Censor Forbidden Clones of CD4 T Cells in Autoimmune Diabetes
Failure to Censor Forbidden Clones of CD4 T Cells in Autoimmune Diabetes
Ann Marshak-Rothstein,
University of Massachusetts Medical School, USA
Short Talk: Activation of Autoreactive B Cells by BCR/TLR Dual Engagement
Short Talk: Activation of Autoreactive B Cells by BCR/TLR Dual Engagement
17:00—19:00
Anergy and Apoptosis in Peripheral T Cell Tolerance
Meeting has ended...abstracts no longer viewable online.
*
Abul K. Abbas,
University of California, San Francisco, USA
Anergy and Apoptosis in Peripheral T Cell Tolerance
Anergy and Apoptosis in Peripheral T Cell Tolerance
Andreas E. Strasser,
Walter and Eliza Hall Institute of Medical Research, Australia
BH3-Only Members of the Bcl-2 Family Are Critical Inducers of Apoptosis and Preclude Autoimmunity
BH3-Only Members of the Bcl-2 Family Are Critical Inducers of Apoptosis and Preclude Autoimmunity
Luk Van Parijs,
Massachusetts Institute of Technology, USA
Short Talk: Regulation of Regulatory T Cell Development and Function by IL-2
Short Talk: Regulation of Regulatory T Cell Development and Function by IL-2
20:00—22:00
Poster Session 2: B Cell Tolerance - 2/Anergy and Apoptosis in Peripheral T Cell Tolerance
08:00—11:00
Immune Suppression
Meeting has ended...abstracts no longer viewable online.
Jean François Bach,
American Autoimmune Related Diseases Association, Inc., USA
CD4+ Regulatory Cells
CD4+ Regulatory Cells
*
Jeffrey A. Bluestone,
University of California, San Francisco, USA
Regulation of Autoimmunity in Ongoing Responses
Regulation of Autoimmunity in Ongoing Responses
Ethan M. Shevach,
NIAID, National Institutes of Health, USA
Control of Autoimmunity by Regulatory T Cells88
Control of Autoimmunity by Regulatory T Cells88
Fred J. Ramsdell,
Parker Institute for Cancer Immunotherapy, USA
Short Talk: A Novel Transcription Factor Involved in CD4+25+ T Cell Function
Short Talk: A Novel Transcription Factor Involved in CD4+25+ T Cell Function
Yang-Xin Fu,
utsouthwestern medical center, USA
Short Talk: The Regulation of T Cell Homeostasis and Autoimmunity by T Cell Derived LIGHT
Short Talk: The Regulation of T Cell Homeostasis and Autoimmunity by T Cell Derived LIGHT
17:00—19:00
APCs and Peripheral Activation vs. Tolerance
Meeting has ended...abstracts no longer viewable online.
Marc K. Jenkins,
University of Minnesota Medical School, USA
Mechanisms of CD4 T Cell Tolerance Induced by Peptide Antigen in the Absence of Inflammation
Mechanisms of CD4 T Cell Tolerance Induced by Peptide Antigen in the Absence of Inflammation
Ralph M. Steinman,
Rockefeller University, USA
Dendritic Cells and the Induction of Peripheral T Cell Tolerance
Dendritic Cells and the Induction of Peripheral T Cell Tolerance
*
Linda A. Sherman,
The Scripps Research Institute, USA
Life, Death, and the Pursuit of Immortality by CD8 T Lymphocytes.
Life, Death, and the Pursuit of Immortality by CD8 T Lymphocytes.
Gordon Freeman,
Dana Farber Cancer Institute, USA
Short Talk: Blockade of PD-1 Ligands on Dendritic Cells and Tumors Enhances T Cell Activation and Cytokine Production
Short Talk: Blockade of PD-1 Ligands on Dendritic Cells and Tumors Enhances T Cell Activation and Cytokine Production
20:00—22:00
Poster Session 3: Immune Suppression/APCs and Peripheral Activation vs. Tolerance
08:00—11:00
Signaling in Activation vs. Tolerance. Session Sponsored in part by SangStat
Meeting has ended...abstracts no longer viewable online.
Arthur Weiss,
University of California, San Francisco, USA
CD45 Turns T Cells On and Off
CD45 Turns T Cells On and Off
*
Ed Palmer,
University of Basel Hospital, Switzerland
T Cell Receptor Regulation of T Cell Biology
T Cell Receptor Regulation of T Cell Biology
Daniel L. Mueller,
University of Minnesota Medical School, USA
Transcriptional Regulation by B7 and CD28 Costimulatory Signals
Transcriptional Regulation by B7 and CD28 Costimulatory Signals
17:00—19:00
Tolerance in Cancer and Transplantation
Meeting has ended...abstracts no longer viewable online.
James P. Allison,
University of Texas MD Anderson Cancer Center, USA
More is Less: New Insights into The Mechanisms of Negative Costimulation by CTLA-4 and its Manipulation in Tumor Immunotherapy
More is Less: New Insights into The Mechanisms of Negative Costimulation by CTLA-4 and its Manipulation in Tumor Immunotherapy
Hyam I. Levitsky,
Juno Therapeutics, USA
Tumor Specific CD4+ T Cell Tolerance- Concomitant Immunity Revisited.
Tumor Specific CD4+ T Cell Tolerance- Concomitant Immunity Revisited.
*
Laurence A. Turka,
Massachusetts General Hospital, USA
Clonal Size Restriction and Tolerance
Clonal Size Restriction and Tolerance
Kathryn J. Wood,
University of Oxford, UK
Tolerance in Transplantation: Epitope Spreading and Immune Tolerance
Tolerance in Transplantation: Epitope Spreading and Immune Tolerance
20:00—22:00
Poster Session 4: Signaling in Activation vs. Tolerance/Tolerance in Cancer and Transplantation/Tolerance in Infectious Disease and Autoimmunity/Therapeutic Approaches
08:00—11:00
Tolerance in Infectious Disease and Autoimmunity
Meeting has ended...abstracts no longer viewable online.
*
Stephen D. Miller,
Northwestern University Medical School, USA
Mechanisms of Intrinsic and Induced Regulation of Relapsing-Remitting Experimental Autoimmune Encephalomyelitis
Mechanisms of Intrinsic and Induced Regulation of Relapsing-Remitting Experimental Autoimmune Encephalomyelitis
Matthias G. von Herrath,
Novo Nordisk and La Jolla Institute for Allergy and Immunology, USA
Autoreactive CD4+ Cells, Bystander Suppression and Virus Infections
Autoreactive CD4+ Cells, Bystander Suppression and Virus Infections
Maria Grazia Roncarolo,
Stanford University School of Medicine, USA
Critical Cytokines in the Generation and Function of T Regulatory Cells
Critical Cytokines in the Generation and Function of T Regulatory Cells
Nora E. Sarvetnick,
University of Nebraska Medical Center, USA
Regulation of Autoimmunity
Regulation of Autoimmunity
17:00—19:00
Therapeutic Approaches
Meeting has ended...abstracts no longer viewable online.
*
C. Garrison Fathman,
Stanford University, USA
Adoptive Cellular Gene Therapy
Adoptive Cellular Gene Therapy
Kevan C. Herold,
Yale University, USA
Preservation of Insulin Production in Type 1 Diabetes with a FcR Non-Binding Anti-CD3 mAb (hOKT3gamma1(Ala-Ala))
Preservation of Insulin Production in Type 1 Diabetes with a FcR Non-Binding Anti-CD3 mAb (hOKT3gamma1(Ala-Ala))
Terry B. Strom,
Beth Israel Deaconess Medical Center, USA
Harnessing Apoptosis to Promote Transplantation Tolerance
Harnessing Apoptosis to Promote Transplantation Tolerance
*Session Chair †Invited, not yet responded.
We gratefully acknowledge the generous grant for this conference provided by:
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Development, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org, Phone:+1 970-262-2676 |
